Incidence, Clinical Features, Management, and Prevention of Herpes Zoster in Patients Receiving Antitumor Necrosis Factor Therapy: A Clinical Review

Byung Soo Kim; Emanual Maverakis; Clarie Alexanian; Jenny Z. Wang; Siba P. Raychaudhuri

doi:10.1177/1203475420914622

Incidence, Clinical Features, Management, and Prevention of Herpes Zoster in Patients Receiving Antitumor Necrosis Factor Therapy: A Clinical Review

Byung Soo Kim, Emanual Maverakis, Clarie Alexanian, Jenny Z. Wang, Siba P. Raychaudhuri

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Abstract

Tumor necrosis factor (TNF) inhibitors have been used as an excellent therapeutic option in a variety of chronic inflammatory conditions. However, a recognized significant adverse effect of TNF inhibitor therapy is the increased risk of infections. The influence of TNF inhibitors on the course of coexisting or newly developed viral infections has not been extensively investigated. Therefore, we reviewed the recent publications to highlight the incidence, clinical features, management, and prevention of herpes zoster in patients who are receiving TNF inhibitors.

Original language	English (US)
Journal	Journal of Cutaneous Medicine and Surgery
DOIs	https://doi.org/10.1177/1203475420914622
State	Accepted/In press - Jan 1 2020

Keywords

anti-TNF therapy
herpes zoster
TNF antagonists
TNF inhibitors
vaccination
varicella zoster virus

ASJC Scopus subject areas

Surgery
Dermatology

Access to Document

10.1177/1203475420914622

Cite this

Incidence, Clinical Features, Management, and Prevention of Herpes Zoster in Patients Receiving Antitumor Necrosis Factor Therapy : A Clinical Review. / Kim, Byung Soo; Maverakis, Emanual; Alexanian, Clarie; Wang, Jenny Z.; Raychaudhuri, Siba P.

In: Journal of Cutaneous Medicine and Surgery, 01.01.2020.

Research output: Contribution to journal › Review article › peer-review

@article{971192a0dc6d439ab0dd45a05ed3462d,

title = "Incidence, Clinical Features, Management, and Prevention of Herpes Zoster in Patients Receiving Antitumor Necrosis Factor Therapy: A Clinical Review",

abstract = "Tumor necrosis factor (TNF) inhibitors have been used as an excellent therapeutic option in a variety of chronic inflammatory conditions. However, a recognized significant adverse effect of TNF inhibitor therapy is the increased risk of infections. The influence of TNF inhibitors on the course of coexisting or newly developed viral infections has not been extensively investigated. Therefore, we reviewed the recent publications to highlight the incidence, clinical features, management, and prevention of herpes zoster in patients who are receiving TNF inhibitors.",

keywords = "anti-TNF therapy, herpes zoster, TNF antagonists, TNF inhibitors, vaccination, varicella zoster virus",

author = "Kim, {Byung Soo} and Emanual Maverakis and Clarie Alexanian and Wang, {Jenny Z.} and Raychaudhuri, {Siba P.}",

year = "2020",

month = jan,

day = "1",

doi = "10.1177/1203475420914622",

language = "English (US)",

journal = "Journal of Cutaneous Medicine and Surgery",

issn = "1203-4754",

publisher = "Decker Publishing",

}

TY - JOUR

T1 - Incidence, Clinical Features, Management, and Prevention of Herpes Zoster in Patients Receiving Antitumor Necrosis Factor Therapy

T2 - A Clinical Review

AU - Kim, Byung Soo

AU - Maverakis, Emanual

AU - Alexanian, Clarie

AU - Wang, Jenny Z.

AU - Raychaudhuri, Siba P.

PY - 2020/1/1

Y1 - 2020/1/1

N2 - Tumor necrosis factor (TNF) inhibitors have been used as an excellent therapeutic option in a variety of chronic inflammatory conditions. However, a recognized significant adverse effect of TNF inhibitor therapy is the increased risk of infections. The influence of TNF inhibitors on the course of coexisting or newly developed viral infections has not been extensively investigated. Therefore, we reviewed the recent publications to highlight the incidence, clinical features, management, and prevention of herpes zoster in patients who are receiving TNF inhibitors.

AB - Tumor necrosis factor (TNF) inhibitors have been used as an excellent therapeutic option in a variety of chronic inflammatory conditions. However, a recognized significant adverse effect of TNF inhibitor therapy is the increased risk of infections. The influence of TNF inhibitors on the course of coexisting or newly developed viral infections has not been extensively investigated. Therefore, we reviewed the recent publications to highlight the incidence, clinical features, management, and prevention of herpes zoster in patients who are receiving TNF inhibitors.

KW - anti-TNF therapy

KW - herpes zoster

KW - TNF antagonists

KW - TNF inhibitors

KW - vaccination

KW - varicella zoster virus

UR - http://www.scopus.com/inward/record.url?scp=85083277525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85083277525&partnerID=8YFLogxK

U2 - 10.1177/1203475420914622

DO - 10.1177/1203475420914622

M3 - Review article

C2 - 32238066

AN - SCOPUS:85083277525

JO - Journal of Cutaneous Medicine and Surgery

JF - Journal of Cutaneous Medicine and Surgery

SN - 1203-4754

ER -

Incidence, Clinical Features, Management, and Prevention of Herpes Zoster in Patients Receiving Antitumor Necrosis Factor Therapy: A Clinical Review

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this